Viewing Study NCT07478302


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 12:22 PM
Study NCT ID: NCT07478302
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-17
First Post: 2026-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module